BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
Written By: BrightFocus Editorial Staff
BrightFocus Foundation’s 2025 research portfolios showcase the groundbreaking biomedical studies the Foundation is supporting worldwide to accelerate cures for Alzheimer’s disease, macular degeneration, and glaucoma.
Made possible through the generosity of our donors, these projects are carefully vetted by world-renowned scientists who serve on the Foundation’s Scientific Review Committees, ensuring the most innovative and promising ideas that will advance our understanding of these diseases of mind and sight.
BrightFocus is deeply grateful to its donors, whose generosity empowers the next generation of researchers to pursue innovative, bold, and promising science, bringing us closer to novel treatments, prevention strategies, and cures for Alzheimer’s disease, macular degeneration, and glaucoma. Learn more about how you can support this work.
Alzheimer’s Disease Research is currently investing $28.4 million in 111 research projects across 13 countries.
View the Alzheimer’s Disease Research Portfolio in magazine format or view a printable format (PDF).
Macular Degeneration Research is currently investing $14.1 million in 44 research projects across six countries.
View the Macular Degeneration Research Portfolio in magazine format or view a printable format (PDF).
National Glaucoma Research is currently investing $5.6 million in 31 research projects across five countries.
View the National Glaucoma Research Portfolio in magazine format or view a printable format (PDF).
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Jimmy Liu, PhD, has joined BrightFocus as Director of Vision Science Programs, bringing deep expertise in eye disease research and a passion for advancing the next generation of vision treatments.
BrightFocus Foundation's new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
The proposed 2026 federal budget released by the Trump administration would deliver crippling cuts to the National Institutes of Health (NIH). These cuts would threaten essential progress in the fight against Alzheimer’s disease, macular degeneration, and glaucoma—diseases of mind and sight impacting 1 in 7 Americans over age 40.
Donate Now to Fund Critical Research
Your gift today can help drive innovation in Alzheimer's, macular degeneration, and glaucoma research. By donating, you’ll support life-changing research and provide valuable resources for those affected by these devastating diseases. Give now to fuel hope and bring us closer to finding cures.
